[
  {
    "ts": null,
    "headline": "BMY Declares $0.60 Dividend, Extends 95-Year Streak",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is the third biopharmaceutical company on the list of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 17, the company announced a quarterly cash dividend of $0.60 per share on its common stock. This is the 95th consecutive year that the conglomerate has paid a dividend. […]",
    "url": "https://finnhub.io/api/news?id=5a7ebc7f231c3065ed671fbd05719d9973562477d482a05a3caef884b067af87",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750800106,
      "headline": "BMY Declares $0.60 Dividend, Extends 95-Year Streak",
      "id": 135512142,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is the third biopharmaceutical company on the list of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 17, the company announced a quarterly cash dividend of $0.60 per share on its common stock. This is the 95th consecutive year that the conglomerate has paid a dividend. […]",
      "url": "https://finnhub.io/api/news?id=5a7ebc7f231c3065ed671fbd05719d9973562477d482a05a3caef884b067af87"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Advance Late Afternoon",
    "summary": "Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 1.3% and the",
    "url": "https://finnhub.io/api/news?id=e8984d4fe9efd224aa16742acb2753cce79460f727bf07e5e5c7907d70429424",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750795408,
      "headline": "Sector Update: Health Care Stocks Advance Late Afternoon",
      "id": 135510381,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 1.3% and the",
      "url": "https://finnhub.io/api/news?id=e8984d4fe9efd224aa16742acb2753cce79460f727bf07e5e5c7907d70429424"
    }
  },
  {
    "ts": null,
    "headline": "Cigna Sues Bristol Myers Over Alleged Monopoly on Cancer Drug Pomalyst",
    "summary": "Cigna Group (CI) filed a lawsuit against Bristol Myers Squibb (BMY), accusing the pharmaceutical gia",
    "url": "https://finnhub.io/api/news?id=cd70034e6fcad82a9a80f33b07b0415040f3302fc256c8a72fb8710cbf29f4b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750789154,
      "headline": "Cigna Sues Bristol Myers Over Alleged Monopoly on Cancer Drug Pomalyst",
      "id": 135510896,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Cigna Group (CI) filed a lawsuit against Bristol Myers Squibb (BMY), accusing the pharmaceutical gia",
      "url": "https://finnhub.io/api/news?id=cd70034e6fcad82a9a80f33b07b0415040f3302fc256c8a72fb8710cbf29f4b6"
    }
  },
  {
    "ts": null,
    "headline": "EXEL Stock Rises on Positive Data From Colorectal Cancer Study",
    "summary": "EXEL jumps 7.4% as STELLAR-303 trial hits key survival goal in colorectal cancer, boosting hopes for an approval of zanzalintinib.",
    "url": "https://finnhub.io/api/news?id=ec78ab15a54176d6f3131d16a7c6fd081afeece1ff982674fbe2a511f3eeb434",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750772400,
      "headline": "EXEL Stock Rises on Positive Data From Colorectal Cancer Study",
      "id": 135503055,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "EXEL jumps 7.4% as STELLAR-303 trial hits key survival goal in colorectal cancer, boosting hopes for an approval of zanzalintinib.",
      "url": "https://finnhub.io/api/news?id=ec78ab15a54176d6f3131d16a7c6fd081afeece1ff982674fbe2a511f3eeb434"
    }
  },
  {
    "ts": null,
    "headline": "Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock",
    "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=e824c45e10d726bf9abad3c85d651d3f6c0628fb5dbf0536ddc4971a32217805",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750770002,
      "headline": "Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock",
      "id": 135503057,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=e824c45e10d726bf9abad3c85d651d3f6c0628fb5dbf0536ddc4971a32217805"
    }
  },
  {
    "ts": null,
    "headline": "10 'Safer' Dividend Buys Of Barron's Better Bets Than T-Bills For June",
    "summary": "10 'Safer' Dividend Buys Of Barron's Better Bets Than T-Bills For June",
    "url": "https://finnhub.io/api/news?id=876cd6e780cc5104c978a8df939dc71739dafda7d1a49f31c54a5968375461bf",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750760206,
      "headline": "10 'Safer' Dividend Buys Of Barron's Better Bets Than T-Bills For June",
      "id": 135499272,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=876cd6e780cc5104c978a8df939dc71739dafda7d1a49f31c54a5968375461bf"
    }
  },
  {
    "ts": null,
    "headline": "Bargain Alert: I'm Buying Monthly Dividends Up To 7% Yield",
    "summary": "Discover 2 undervalued monthly dividend stocks with strong growth potential, high credit ratings, and reliable yields.",
    "url": "https://finnhub.io/api/news?id=5a0d85e4a6818dd6f73e9515e59320986d3e575cedb0af5304267710849b74c6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750755600,
      "headline": "Bargain Alert: I'm Buying Monthly Dividends Up To 7% Yield",
      "id": 135497478,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2183415939/image_2183415939.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Discover 2 undervalued monthly dividend stocks with strong growth potential, high credit ratings, and reliable yields.",
      "url": "https://finnhub.io/api/news?id=5a0d85e4a6818dd6f73e9515e59320986d3e575cedb0af5304267710849b74c6"
    }
  },
  {
    "ts": null,
    "headline": "2 Dividend Aristocrats Bargains To Buy And 'Never Let Go'",
    "summary": "Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. Read about two such stocks that are undervalued vs. historical norms.",
    "url": "https://finnhub.io/api/news?id=bcae1d83887a65e6c9f9053eb28696afd7ae4c7b3be1ead657c7a557d5bd0369",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750752000,
      "headline": "2 Dividend Aristocrats Bargains To Buy And 'Never Let Go'",
      "id": 135496728,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1652791120/image_1652791120.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. Read about two such stocks that are undervalued vs. historical norms.",
      "url": "https://finnhub.io/api/news?id=bcae1d83887a65e6c9f9053eb28696afd7ae4c7b3be1ead657c7a557d5bd0369"
    }
  }
]